Cancer Family
Thoracic Neoplasm
CI-CAN-00000054Explore in graph →
Non-malignant2,893 active trials51 approved drugs626 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000054Explore in graph →
Clinical trials
12,163 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03725423 | Apatinib for Advanced Lung Squmamous Carcinoma | unknown | Phase 4 | 50 | Xuzhou Central HospitalOTHER | 0 | Oct 31, 2018 | clinicaltrials |
| NCT02151149 | Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly(ABOUND 70+) | completed | Phase 4 | 143 | CelgeneINDUSTRY | 1 | Sep 24, 2018 | clinicaltrials |
| NCT03384511 | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | completed | Phase 4 | 38 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03394222 | Effect of Preoperative Budesonide Inhalation on Arterial Blood Oxygenation and Intrapulmonary Shunt During OLV | completed | Phase 4 | 50 | Fujian Medical University Union HospitalOTHER | 0 | Jan 9, 2018 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT02695290 | Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) | terminated | Phase 4 | 1 | Boehringer IngelheimINDUSTRY | 1 | Sep 18, 2017 | clinicaltrials |
| NCT03264794 | the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer) | unknown | Phase 4 | 100 | Jiangsu Famous Medical Technology Co., Ltd.INDUSTRY | 0 | Aug 29, 2017 | clinicaltrials |
| NCT02404675 | High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation(INCREASE) | unknown | Phase 4 | 240 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 28, 2017 | clinicaltrials |
| NCT02346318 | The Randomized Controlled Clinical Trial of Kushen Injection | unknown | Phase 4 | 240 | Beijing Zheng Ju Medical Technology Co., Ltd.INDUSTRY | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01783236 | Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery | completed | Phase 4 | 16 | Weill Medical College of Cornell UniversityOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT02348450 | Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer | unknown | Phase 4 | 308 | Guangdong Association of Clinical TrialsOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT02316327 | Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab | completed | Phase 4 | 19 | Fundacion Clinic per a la Recerca BiomédicaOTHER | 1 | Oct 5, 2016 | clinicaltrials |
| NCT01066884 | A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 4 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Aug 24, 2016 | clinicaltrials |
| NCT02804646 | Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma | unknown | Phase 4 | 100 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 21, 2016 | clinicaltrials |
| NCT00451906 | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. | completed | Phase 4 | 2,252 | Hoffmann-La RocheINDUSTRY | 40 | May 24, 2016 | clinicaltrials |
| NCT02778893 | Conmana Combined With Thalidomide to Treat NSCLC | unknown | Phase 4 | 67 | Henan Provincial People's HospitalOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT01320501 | Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer(REALME) | suspended | Phase 4 | 100 | National Guard Health AffairsOTHER_GOV | 1 | May 13, 2016 | clinicaltrials |
| NCT02246023 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | completed | Phase 4 | 78 | Daniel FranzenOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02031601 | Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer(TCL-1) | unknown | Phase 4 | 250 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT00492843 | Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis | terminated | Phase 4 | 20 | Chinese Society of Lung CancerOTHER | 1 | Feb 17, 2016 | clinicaltrials |
| NCT00770588 | Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)(INFORM) | completed | Phase 4 | 296 | AstraZenecaINDUSTRY | 1 | Feb 8, 2016 | clinicaltrials |
| NCT01658280 | Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies | completed | Phase 4 | 253 | Azienda Ospedaliero, Universitaria Ospedali RiunitiOTHER | 1 | Feb 3, 2016 | clinicaltrials |
| NCT01402089 | Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients | completed | Phase 4 | 54 | Markus JoergerOTHER | 1 | Feb 2, 2016 | clinicaltrials |
| NCT01609543 | A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations | completed | Phase 4 | 62 | Hoffmann-La RocheINDUSTRY | 3 | Feb 1, 2016 | clinicaltrials |
| NCT02000531 | Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population | completed | Phase 4 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Jan 13, 2016 | clinicaltrials |
| NCT01646450 | First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients | unknown | Phase 4 | 35 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 9, 2015 | clinicaltrials |
| NCT02513355 | Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research | unknown | Phase 4 | 400 | Nanjing NingQi Medicine Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 4, 2015 | clinicaltrials |
| NCT01064050 | Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers(SPOC) | terminated | Phase 4 | 75 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01196078 | A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 4 | 114 | Hoffmann-La RocheINDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT02504801 | Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD | unknown | Phase 4 | 73 | Xiuyi ZhiOTHER | 0 | Jul 22, 2015 | clinicaltrials |
| NCT00747916 | Safety, Efficacy, and Side Effects Study of Interventional Cryotherapy in the Pleural Space("ICE PLS") | terminated | Phase 4 | 3 | CSA Medical, Inc.INDUSTRY | 1 | Jul 16, 2015 | clinicaltrials |
| NCT01926171 | Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases | unknown | Phase 4 | 80 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jul 15, 2015 | clinicaltrials |
| NCT02497118 | Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC | completed | Phase 4 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT02490059 | Ultrathin Bronchoscopy for Solitary Pulmonary Nodules(Babyscope) | completed | Phase 4 | 40 | University of ZurichOTHER | 1 | Jul 3, 2015 | clinicaltrials |
| NCT01741506 | Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer(COPPVATS) | completed | Phase 4 | 116 | Thomas Decker ChristensenOTHER | 1 | Jun 23, 2015 | clinicaltrials |
| NCT01287754 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations | completed | Phase 4 | 24 | Hoffmann-La RocheINDUSTRY | 1 | Jun 2, 2015 | clinicaltrials |
| NCT01720901 | Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy | suspended | Phase 4 | 20 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | May 22, 2015 | clinicaltrials |
| NCT01230710 | A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression | completed | Phase 4 | 51 | Hoffmann-La RocheINDUSTRY | 1 | Mar 30, 2015 | clinicaltrials |
| NCT02399566 | Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma | unknown | Phase 4 | 300 | Hunan Province Tumor HospitalOTHER | 0 | Mar 26, 2015 | clinicaltrials |
| NCT02195453 | Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer | unknown | Phase 4 | 520 | Shandong Cancer Hospital and InstituteOTHER | 0 | Jul 21, 2014 | clinicaltrials |
| NCT01465243 | Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose | completed | Phase 4 | 32 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT00747773 | Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung(CSAir 1) | completed | Phase 4 | 21 | CSA Medical, Inc.INDUSTRY | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00883675 | Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer | completed | Phase 4 | 133 | Michael MannNETWORK | 2 | Dec 18, 2013 | clinicaltrials |
| NCT00762346 | Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | completed | Phase 4 | 156 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00765687 | Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates(BLEST) | completed | Phase 4 | 432 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00536107 | Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 4 | 14 | AstraZenecaINDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00925444 | Staple-line Reinforcement for Prevention of Pulmonary Air Leakage(SPIRAL) | completed | Phase 4 | 380 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 18, 2013 | clinicaltrials |
| NCT01020786 | A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients | completed | Phase 4 | 109 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2018source: clinicaltrials